{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:13:34Z","timestamp":1778872414081,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"RICORS","award":["RD21\/0006\/0012"],"award-info":[{"award-number":["RD21\/0006\/0012"]}]},{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>A consensus on the management of anticoagulated patients in the acute phase of ischaemic stroke has not yet been established. We aimed to evaluate clinical outcomes in such patients based on the continuation or discontinuation of anticoagulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective study of patients with acute ischaemic stroke and cardioembolic source receiving anticoagulant therapy is done. Patients were classified based on the continuation or discontinuation of anticoagulation at admission. Clinical outcomes, haemorrhagic and ischaemic events were assessed. Multivariate logistic regression analysis, propensity score matching (PSM) analysis and a sub-analysis of patients with severe ischaemic stroke at admission (NIHSS score\u2009\u2265\u200915) were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Anticoagulation was continued in 147 (78.8%) of 186 patients. Patients continuing anticoagulant had lower NIHSS (median 5 vs 18, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). There were no differences in haemorrhagic or ischaemic events. In the multivariate analysis, good functional outcome at discharge was higher in the continuation group, OR (CI95%) 3.77 (1.2\u201311.2). PSM analysis adjusted for potential confounders such as NIHSS had higher rates of good functional outcomes at discharge (80% vs 36%, <jats:italic>p<\/jats:italic>\u2009=\u20090.004) and at 90 days (76% vs 44%, <jats:italic>p<\/jats:italic>\u2009=\u20090.042) in the continuation group. Patients with severe stroke in this group had lower 90-day mortality (34.6% vs 62.5%, <jats:italic>p<\/jats:italic>\u2009=\u20090.045) and higher rates of good clinical outcome at discharge (33.3% vs 8.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.032). No differences were observed in 90-day haemorrhagic or ischaemic events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Continuation of anticoagulation in patients with acute ischaemic stroke and cardioembolic source did not increase the risk of intracranial haemorrhage and may be associated with better functional outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00415-024-12204-8","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T10:02:08Z","timestamp":1712311328000},"page":"4086-4094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Keeping prior anticoagulation treatment in the acute phase of ischaemic stroke: the REKOALA study"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6533-3581","authenticated-orcid":false,"given":"Ricardo","family":"Rigual","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rodr\u00edguez-Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Lorenzo-Di\u00e9guez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Fern\u00e1ndez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Torres Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Lastras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Ruiz-Ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Alonso","family":"de Leci\u00f1ana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"de Celis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Casado-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Herv\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Exuperio","family":"D\u00edez-Tejedor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"issue":"6","key":"12204_CR1","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/STROKEAHA.116.012865","volume":"47","author":"N Henninger","year":"2016","unstructured":"Henninger N, Goddeau RP, Karmarkar A, Helenius J, McManus DD (2016) Atrial fibrillation is associated with a worse 90-day outcome than other cardioembolic stroke subtypes. Stroke 47(6):1486\u20131492. https:\/\/doi.org\/10.1161\/STROKEAHA.116.012865","journal-title":"Stroke"},{"issue":"10","key":"12204_CR2","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/JNNP-2021-326166","volume":"92","author":"S Yaghi","year":"2021","unstructured":"Yaghi S, Henninger N, Giles JA et al (2021) Ischemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study. J Neurol Neurosurg Psychiatry 92(10):1062. https:\/\/doi.org\/10.1136\/JNNP-2021-326166","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"12204_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ANA.25700","volume":"87","author":"DJ Seiffge","year":"2020","unstructured":"Seiffge DJ, De Marchis GM, Koga M et al (2020) Ischemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. Ann Neurol 87(5):677\u2013687. https:\/\/doi.org\/10.1002\/ANA.25700","journal-title":"Ann Neurol"},{"key":"12204_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2020.575634","volume":"11","author":"R Guti\u00e9rrez-Z\u00fa\u00f1iga","year":"2020","unstructured":"Guti\u00e9rrez-Z\u00fa\u00f1iga R, Rigual R, Torres-Iglesias G et al (2020) Long-term anticoagulation in secondary ischemic stroke prevention: the prospective multicenter RESTAIC registry. Front Neurol 11:575634. https:\/\/doi.org\/10.3389\/FNEUR.2020.575634","journal-title":"Front Neurol"},{"issue":"16","key":"12204_CR5","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/EURHEARTJ\/EHY136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS et al (2018) The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39(16):1330\u20131393. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHY136","journal-title":"Eur Heart J"},{"issue":"2","key":"12204_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1136\/JNNP-2021-327236","volume":"93","author":"GM De Marchis","year":"2022","unstructured":"De Marchis GM, Seiffge DJ, Schaedelin S et al (2022) Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis. J Neurol Neurosurg Psychiatry 93(2):119\u2013125. https:\/\/doi.org\/10.1136\/JNNP-2021-327236","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12204_CR7","doi-asserted-by":"publisher","unstructured":"Fischer U, Koga M, Strbian D, et al (2023) Early versus later anticoagulation for stroke with atrial fibrillation. N Engl J Med. doi:https:\/\/doi.org\/10.1056\/NEJMOA2303048\/SUPPL_FILE\/NEJMOA2303048_DATA-SHARING.PDF. Published online May 24, 2023","DOI":"10.1056\/NEJMOA2303048\/SUPPL_FILE\/NEJMOA2303048_DATA-SHARING.PDF"},{"issue":"5","key":"12204_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/17474930211057722","volume":"17","author":"JG Best","year":"2022","unstructured":"Best JG, Arram L, Ahmed N et al (2022) Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke 17(5):583\u2013589. https:\/\/doi.org\/10.1177\/17474930211057722","journal-title":"Int J Stroke"},{"issue":"9","key":"12204_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1177\/1747493019870651","volume":"14","author":"BT King","year":"2019","unstructured":"King BT, Lawrence PD, Milling TJ, Warach SJ (2019) Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START): Methodology of a pragmatic, response-adaptive, prospective randomized clinical trial. Int J Stroke 14(9):977. https:\/\/doi.org\/10.1177\/1747493019870651","journal-title":"Int J Stroke"},{"issue":"7","key":"12204_CR10","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1161\/STROKEAHA.118.021514","volume":"49","author":"AE Groot","year":"2018","unstructured":"Groot AE, Vermeij JDM, Westendorp WF, Nederkoorn PJ, Van De Beek D, Coutinho JM (2018) Continuation or discontinuation of anticoagulation in the early phase after acute ischemic stroke. Stroke 49(7):1762\u20131765. https:\/\/doi.org\/10.1161\/STROKEAHA.118.021514","journal-title":"Stroke"},{"issue":"11","key":"12204_CR11","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","volume":"30","author":"M Fiorelli","year":"1999","unstructured":"Fiorelli M, Bastianello S, Von Kummer R et al (1999) Hemorrhagic transformation within 36 h of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 30(11):2280\u20132284. https:\/\/doi.org\/10.1161\/01.STR.30.11.2280","journal-title":"Stroke"},{"issue":"4","key":"12204_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/2396987318787124","volume":"3","author":"D Munn","year":"2018","unstructured":"Munn D, Abdul-Rahim AH, Fischer U, Werring DJ, Robinson TG, Dawson J (2018) A survey of opinion: when to start oral anticoagulants in patients with acute ischaemic stroke and atrial fibrillation? Eur Stroke J 3(4):355\u2013360. https:\/\/doi.org\/10.1177\/2396987318787124","journal-title":"Eur Stroke J"},{"issue":"20","key":"12204_CR13","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1093\/EURHEARTJ\/EHAD200","volume":"44","author":"AP Benz","year":"2023","unstructured":"Benz AP, Hohnloser SH, Eikelboom JW et al (2023) Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. Eur Heart J 44(20):1807\u20131814. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAD200","journal-title":"Eur Heart J"},{"key":"12204_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/JCM11174981","author":"L Palaiodimou","year":"2022","unstructured":"Palaiodimou L, Stefanou MI, Katsanos AH et al (2022) Early anticoagulation in patients with acute ischemic stroke due to atrial fibrillation: a systematic review and meta-analysis. J Clin Med. https:\/\/doi.org\/10.3390\/JCM11174981","journal-title":"J Clin Med"},{"issue":"14","key":"12204_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","volume":"146","author":"J Oldgren","year":"2022","unstructured":"Oldgren J, \u00c5sberg S, Hijazi Z, Wester P, Bertilsson M, Norrving B (2022) Early versus delayed non-vitamin k antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study. Circulation 146(14):1056\u20131066. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060666","journal-title":"Circulation"},{"issue":"5","key":"12204_CR16","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/STROKEAHA.121.036695","volume":"53","author":"S Kimura","year":"2022","unstructured":"Kimura S, Toyoda K, Yoshimura S et al (2022) Practical \u201c1-2-3-4-day\u201d rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation: combined hospital-based cohort study. Stroke 53(5):1540\u20131549. https:\/\/doi.org\/10.1161\/STROKEAHA.121.036695","journal-title":"Stroke"},{"key":"12204_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007034","author":"M Paciaroni","year":"2017","unstructured":"Paciaroni M, Agnelli G, Falocci N et al (2017) Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non\u2013vitamin-K oral anticoagulants (RAF-NOACs) study. J Am Heart Assoc Cardiovasc Cerebrovasc Dis. https:\/\/doi.org\/10.1161\/JAHA.117.007034","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"issue":"8","key":"12204_CR18","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","volume":"46","author":"M Paciaroni","year":"2015","unstructured":"Paciaroni M, Agnelli G, Falocci N et al (2015) Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study. Stroke 46(8):2175\u20132182. https:\/\/doi.org\/10.1161\/STROKEAHA.115.008891","journal-title":"Stroke"},{"issue":"11","key":"12204_CR19","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1161\/STROKEAHA.115.008861\/-\/DC1","volume":"46","author":"A Kassner","year":"2015","unstructured":"Kassner A, Merali Z (2015) Assessment of blood-brain barrier disruption in stroke. Stroke 46(11):3310\u20133315. https:\/\/doi.org\/10.1161\/STROKEAHA.115.008861\/-\/DC1","journal-title":"Stroke"},{"key":"12204_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2021.703258\/FULL","author":"JM Hong","year":"2021","unstructured":"Hong JM, Kim DS, Kim M (2021) Hemorrhagic transformation after ischemic stroke: mechanisms and management. Front Neurol. https:\/\/doi.org\/10.3389\/FNEUR.2021.703258\/FULL","journal-title":"Front Neurol"},{"issue":"5","key":"12204_CR21","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/STROKEAHA.121.035425\/FORMAT\/EPUB","volume":"53","author":"B Tian","year":"2022","unstructured":"Tian B, Tian X, Shi Z et al (2022) Clinical and imaging indicators of hemorrhagic transformation in acute ischemic stroke after endovascular thrombectomy. Stroke 53(5):1674\u20131681. https:\/\/doi.org\/10.1161\/STROKEAHA.121.035425\/FORMAT\/EPUB","journal-title":"Stroke"},{"key":"12204_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/OPENHRT-2019-001187","author":"C Guidoux","year":"2019","unstructured":"Guidoux C, Meseguer E, Ong E et al (2019) Twelve-month outcome in patients with stroke and atrial fibrillation not suitable to oral anticoagulant strategy: the WATCH-AF registry. Open Heart. https:\/\/doi.org\/10.1136\/OPENHRT-2019-001187","journal-title":"Open Heart"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12204-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12204-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12204-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T10:25:19Z","timestamp":1720520719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12204-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["12204"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12204-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"15 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Email address has been changed from ricardojaime.rigual@salud.madrid.org to ricardo.rigual@estudiante.uam.es","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Informed consent was not sought for this study because data was obtained retrospectively and with minimal to no patient risk.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was approved by the La Paz University Hospital Ethics Committee (PI-4488) and by the Spanish Agency of Medicines and Medical Devices (Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios) (RRB-API-2020\u201302).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}